Advertisement

Topics

Aveo Pharma Lands $1.4B Deal with Astellas, A Few Months Ahead of Cancer Trial Result

16:02 EST 16 Feb 2011 |

Aveo Pharmaceuticals has beefed up its cash coffers as it heads into the home stretch of a vitally important clinical test of its lead anti-cancer drug. The Cambridge, MA-based biotech company (NASDAQ:AVEO) has struck its largest deal ever with the major Japanese drugmaker Astellas Pharma. Tokyo-based Astellas is paying Aveo $125 million initially (composed of [...]

Original Article: Aveo Pharma Lands $1.4B Deal with Astellas, A Few Months Ahead of Cancer Trial Result

NEXT ARTICLE

More From BioPortfolio on "Aveo Pharma Lands $1.4B Deal with Astellas, A Few Months Ahead of Cancer Trial Result"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...